샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777370

세계의 혈관 내 카테터 시장

Intravascular Catheters
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 384 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 혈관 내 카테터 시장은 2030년까지 151억 달러에 도달

2024년에 76억 달러로 추정되는 혈관 내 카테터 세계 시장은 2024-2030년간 CAGR 12.0%로 성장하여 2030년에는 151억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 쇼트 PIVC는 CAGR 13.4%를 나타내고, 분석 기간 종료시에는 109억 달러에 이를 것으로 예측됩니다. 통합형/폐쇄형 PIVC 부문의 성장률은 분석 기간중 CAGR 8.9%로 추정됩니다.

미국 시장은 21억 달러, 중국은 CAGR16.4%로 성장 예측

미국의 혈관 내 카테터 시장은 2024년에는 21억 달러에 이를 것으로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 32억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 16.4%로 추정됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 8.6%와 10.8%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 9.5%를 나타낼 전망입니다.

세계의 혈관 내 카테터 시장 - 주요 동향과 촉진요인 정리

혈관 내 카테터는 의료 절차에 어떤 혁명을 가져올 것인가?

혈관 내 카테터 시장은 최소침습적 시술에 대한 수요 증가, 카테터 기술의 발전, 혈관 내 접근이 필요한 만성 질환의 유병률 증가로 인해 크게 성장하고 있습니다. 혈관 내 카테터는 약물 투여, 수액 주입, 혈액 투석, 심혈관 중재술, 중증 환자 모니터링 등 다양한 의료용도에 필수적입니다. 이 카테터는 안전하고 효율적이며 정확한 혈관 접근을 제공하여 기존의 외과적 개입에 따른 합병증을 줄여줍니다.

세계적으로 심혈관 질환(CVD), 암 치료, 투석을 필요로 하는 말기 신부전(ESRD)이 증가함에 따라 병원, 외래수술센터(ASC), 재택치료 현장에서 혈관 내 카테터의 채택이 증가하고 있습니다. 또한, 중재적 심장학, 신경학, 영상의학의 성장으로 혈관성형술, 스텐트삽입술, 혈전제거술 등 정밀한 시술을 위한 특수 유도카테터, 풍선카테터, 마이크로카테터 등의 사용이 확대되고 있습니다.

항균 코팅 카테터, 생체 흡수성 카테터, 카테터 내비게이션 시스템 등의 기술 발전으로 감염 관리, 환자 안전, 시술의 효율성이 향상되고 있습니다. 저침습적 치료로의 전환은 외래 환자에서 카테터 치료의 사용 증가와 함께 지속적인 시장 확대의 원동력이 될 것으로 예측됩니다.

혈관 내 카테터 시장을 형성하는 주요 동향은?

혈관 내 카테터 시장에서 가장 주목할 만한 동향 중 하나는 항균제 및 헤파린 코팅 카테터의 개발입니다. 카테터 관련 혈류감염(CLABSI)과 혈전증은 카테터 장기 사용의 주요 합병증으로 입원 및 사망률 증가로 이어집니다. 이를 해결하기 위해 제조업체들은 은이온, 클로르헥시딘, 항균 코팅을 적용한 카테터를 도입하여 감염 위험을 줄이고 카테터의 수명을 늘리기 위해 노력하고 있습니다.

또 다른 주요 트렌드는 카테터에 스마트 센서와 실시간 모니터링 기능을 통합하는 것입니다. 압력 센서, 무선 연결, 마이크로플루이딕스 기술을 탑재한 스마트 카테터는 지속적인 혈역학 모니터링, 막힘의 조기 발견, 수액 관리 개선을 가능하게 합니다. 이러한 혁신은 특히 중환자실(ICU)과 중재적 심장학 분야에서 실시간 환자 데이터를 통해 결과를 크게 개선할 수 있는 귀중한 기술입니다.

말초 삽입형 중심정맥카테터(PICC)와 중심정맥카테터의 채택이 증가하고 있는 것도 시장을 재편하고 있습니다. PICC는 중심정맥카테터(CVC)를 대체하는 장기 정맥 치료용 카테터로, 반복적인 정맥 천자의 필요성을 줄여주는 카테터입니다. 중간의 혈관 접근을 제공하는 미드 라인 카테터는 외래 환자 및 재택치료에서 널리 사용되고 있으며, 중심정맥관 감염과 관련된 위험 없이 비용 효율적이고 장기적인 정맥 내 치료를 가능하게 하고 있습니다.

또 다른 새로운 트렌드는 생분해성 및 생체 흡수성 카테터의 사용입니다. 기존 폴리머 기반 카테터는 이물질 반응이나 혈전증을 유발할 수 있는 반면, 생분해성 카테터는 시간이 지남에 따라 용해되기 때문에 장기적인 합병증을 최소화할 수 있습니다. 이 혁신은 일시적 카테터 삽입, 신경혈관 중재술, 소아과적 사용 등 잔류 이물질을 최소화하는 것이 중요한 경우에 특히 유용합니다.

또한, 중재 및 진단 카테터 치료 증가는 마이크로카테터와 스티어러블 가이딩 카테터에 대한 수요를 견인하고 있습니다. 이 특수 기기는 혈관성형술, 색전술, 신경중재술, 전기생리학적 시술에 널리 사용되며, 복잡한 혈관구조를 정확하게 탐색할 수 있도록 도와줍니다. 로봇 보조 카테터 내비게이션 시스템의 채택이 증가하고 있으며, 카테터를 이용한 중재시술의 정확성, 효율성, 시술 성공률이 더욱 향상되고 있습니다.

혈관 내 카테터 시장에 영향을 미치는 이슈는 무엇인가?

혈관 내 카테터 기술의 많은 발전에도 불구하고, 몇 가지 문제가 보급과 시장 성장에 걸림돌이 되고 있습니다. 주요 우려 사항 중 하나는 카테터 관련 감염 및 혈전증으로, 심각한 합병증과 입원 기간 연장, 의료비 증가로 이어질 수 있습니다. 항균 코팅과 최첨단 카테터 소재는 감염 위험을 줄이는 데 도움이 되지만, 합병증을 예방하기 위해서는 엄격한 무균 시술과 정기적인 카테터 유지관리가 필수적입니다.

또 다른 큰 과제는 고급 카테터 치료 장비와 시술의 높은 비용입니다. 약물 용출성 카테터, 생체 흡수성 카테터, 센서 일체형 카테터는 고가이기 때문에 저소득 지역에서는 이용하기 어렵습니다. 또한, 일부 국가에서는 카테터를 이용한 첨단 치료에 대한 상환이 제한되어 있어, 환자가 최첨단 치료에 접근하는 데 제한이 있을 수 있습니다.

규제 장벽과 까다로운 승인 절차도 시장 진출기업에게는 과제입니다. FDA(미국 식품의약국), EMA(유럽의약품청), PMDA(의약품의료기기종합기구) 등 의료기기 규제 당국은 새로운 카테터 기술, 코팅, 재료에 대해 엄격한 임상시험 요건을 부과하고 있습니다. 시간이 오래 걸리는 승인 절차는 제품 출시를 지연시키고 개발 비용을 증가시킵니다.

재료의 생체 적합성과 카테터의 내구성도 중요한 문제입니다. 실리콘, 폴리우레탄, PTFE(폴리테트라플루오로에틸렌)로 만든 카테터는 혈전 형성 및 혈관 외상을 방지하기 위해 최적의 유연성, 내꼬임성, 혈행역학적 안정성을 보여야 합니다. 낮은 혈전 형성성을 보장하면서 부드러움과 내구성의 균형을 맞추는 것은 여전히 제조업체의 기술적 과제입니다.

또한, 일부 지역에서는 고급 카테터 치료 교육을 받은 숙련된 의료 전문가의 부족이 제한적인 요인으로 작용하고 있습니다. 중재적 심장 전문의, 영상의학과 전문의, 혈관외과 전문의가 복잡한 카테터 삽입술을 다루기 위해서는 전문적인 훈련이 필요하며, 전문 지식의 부족은 시술의 성공률에 영향을 미칠 수 있습니다.

혈관 내 카테터 시장의 성장을 가속하는 요인은 무엇인가?

혈관 내 카테터 시장의 성장은 심혈관 질환의 유병률 증가, 최소침습적 중재술 증가, 카테터 기술의 지속적인 혁신 등 여러 요인에 의해 이루어지고 있습니다. 주요 촉진요인 중 하나는 관상동맥질환(CAD), 뇌졸중, 말초동맥질환(PAD) 등 심혈관질환의 유병률 증가이며, 이러한 질환은 혈관성형술, 스텐트삽입술, 혈전제거술과 같은 카테터를 이용한 중재가 필요합니다.

또 다른 중요한 원동력은 종양학, 신장학, 신경학 분야에서의 카테터 적용 확대입니다. 카테터를 이용한 화학요법 주입, 말기신부전증(ESRD) 투석 카테터, 뇌졸중 치료용 신경혈관 카테터 등이 시장 성장에 기여하고 있습니다. 전 세계적으로 암과 신장 질환에 대한 부담이 증가하면서 장기적인 혈관 접근 장치에 대한 수요가 증가하고 있습니다.

외래 및 재택 수액 요법의 채택이 증가하고 있는 것도 시장 확대에 더욱 박차를 가하고 있습니다. 말초 삽입형 중심정맥카테터(PICC)와 중앙선 카테터는 장기 항생제 치료, 화학요법, 비경구 영양요법에 널리 사용되고 있으며, 환자는 병원 밖에서 치료를 받을 수 있습니다. 이러한 추세는 만성질환 관리 및 노인 의료에서 특히 중요하며, 재택 정맥 치료는 입원 및 의료비용을 절감할 수 있습니다.

로봇 보조 카테터 내비게이션, 실시간 압력 감지 카테터, 3D 영상 보조 카테터 삽입 등의 기술 발전은 저침습적 혈관 시술의 정확성과 안전성을 높이고 있습니다. AI를 활용한 카테터 삽입 안내 시스템 도입은 합병증 감소, 시술 결과 개선, 시술 시간 단축에 도움을 주고 있습니다.

또한, 혈관 접근 치료 및 카테터 기반 치료 인프라를 개선하기 위한 정부의 이니셔티브와 헬스케어에 대한 투자가 시장 성장을 뒷받침하고 있습니다. 많은 신흥국들이 중재적 심장학 및 투석 센터를 확장하고 있으며, 고품질 혈관 접근 솔루션의 채택을 늘리고 있습니다.

카테터 코팅, 생분해성 소재, 스마트 센서, AI 기반 영상처리 등의 지속적인 발전으로 혈관 내 카테터 시장은 지속적인 성장과 혁신이 예상됩니다. 감염 방지, 비용 효율적인 솔루션, 규제 준수에 집중하는 기업은 전 세계 의료진과 환자의 변화하는 요구를 충족시키는 데 있어 경쟁 우위를 확보할 수 있을 것으로 예측됩니다.

부문

제품(쇼트 PIVC, 통합/클로즈드 PIVC), 용도(종양학, 소화기병학, 신장병학, 감염증학, 기타), 최종 용도(병원, 진료소, 외래수술센터(ASC), 재택치료, 기타)

조사 대상 기업 예

  • AMECATH
  • AngioDynamics, Inc.
  • Angiplast Pvt. Ltd.
  • Argon Medical Devices, Inc.
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company(BD)
  • Boston Scientific Corporation
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Hindustan Syringes & Medical Devices Ltd.
  • ICU Medical, Inc.
  • Johnson & Johnson
  • McKesson Corporation
  • Medline Industries, Inc.
  • Medtronic PLC
  • Nipro Medical Corporation
  • PRODiMED
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Smiths Medical

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.04

Global Intravascular Catheters Market to Reach US$15.1 Billion by 2030

The global market for Intravascular Catheters estimated at US$7.6 Billion in the year 2024, is expected to reach US$15.1 Billion by 2030, growing at a CAGR of 12.0% over the analysis period 2024-2030. Short PIVC, one of the segments analyzed in the report, is expected to record a 13.4% CAGR and reach US$10.9 Billion by the end of the analysis period. Growth in the Integrated / Closed PIVC segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 16.4% CAGR

The Intravascular Catheters market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 16.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.6% and 10.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Intravascular Catheters Market - Key Trends & Drivers Summarized

How Are Intravascular Catheters Revolutionizing Medical Procedures?

The intravascular catheters market is witnessing significant growth due to increasing demand for minimally invasive procedures, advancements in catheter technology, and rising prevalence of chronic diseases requiring vascular access. Intravascular catheters are essential for a wide range of medical applications, including drug administration, fluid infusion, hemodialysis, cardiovascular interventions, and critical care monitoring. These catheters provide safe, efficient, and precise access to blood vessels, reducing complications associated with traditional surgical interventions.

With the global rise in cardiovascular diseases (CVDs), cancer treatments, and end-stage renal disease (ESRD) requiring dialysis, intravascular catheter adoption is increasing across hospitals, ambulatory surgical centers, and home healthcare settings. Additionally, the growth of interventional cardiology, neurology, and radiology has expanded the use of specialized guiding catheters, balloon catheters, and microcatheters for precision-based procedures such as angioplasty, stent placement, and thrombectomy.

Technological advancements, such as antimicrobial-coated catheters, bioabsorbable catheters, and catheter navigation systems, are enhancing infection control, patient safety, and procedural efficiency. The shift toward minimally invasive treatments, coupled with the increasing use of catheter-based therapies in outpatient settings, is expected to drive continued market expansion.

What Are the Key Trends Shaping the Intravascular Catheters Market?

One of the most notable trends in the intravascular catheters market is the development of antimicrobial and heparin-coated catheters. Catheter-associated bloodstream infections (CLABSIs) and thrombosis are major complications in long-term catheter use, leading to increased hospitalizations and mortality rates. To address this, manufacturers are introducing catheters embedded with silver-ion, chlorhexidine, and antimicrobial coatings to reduce infection risks and improve catheter longevity.

Another key trend is the integration of smart sensors and real-time monitoring capabilities in catheters. Smart catheters equipped with pressure sensors, wireless connectivity, and microfluidic technology are enabling continuous hemodynamic monitoring, early detection of blockages, and improved fluid management. These innovations are particularly valuable in intensive care units (ICUs) and interventional cardiology, where real-time patient data can significantly improve outcomes.

The increasing adoption of peripherally inserted central catheters (PICCs) and midline catheters is also reshaping the market. PICCs offer an alternative to central venous catheters (CVCs) for long-term intravenous therapy, reducing the need for repeated venipunctures. Midline catheters, which provide intermediate vascular access, are gaining traction in outpatient settings and home healthcare, enabling cost-effective, extended IV therapy without the risks associated with central line infections.

Another emerging trend is the use of biodegradable and bioresorbable catheters. Traditional polymer-based catheters can cause foreign body reactions and thrombosis, whereas biodegradable catheters dissolve over time, minimizing long-term complications. This innovation is particularly beneficial in temporary catheter placements, neurovascular interventions, and pediatric applications where minimizing residual foreign material is critical.

Additionally, the rise in interventional and diagnostic catheterization procedures is driving demand for microcatheters and steerable guiding catheters. These specialized devices are widely used in angioplasty, embolization, neurointerventions, and electrophysiology procedures, allowing precise navigation through complex vascular structures. The increasing adoption of robot-assisted catheter navigation systems is further enhancing accuracy, efficiency, and procedural success rates in catheter-based interventions.

What Challenges Are Impacting the Intravascular Catheters Market?

Despite the numerous advancements in intravascular catheter technology, several challenges hinder widespread adoption and market growth. One of the primary concerns is catheter-related infections and thrombosis, which can lead to serious complications, extended hospital stays, and increased healthcare costs. While antimicrobial coatings and advanced catheter materials help reduce infection risks, strict aseptic techniques and regular catheter maintenance are essential to prevent complications.

Another major challenge is the high cost of advanced catheterization devices and procedures. Drug-eluting catheters, bioresorbable catheters, and sensor-integrated catheters come at a premium cost, making them less accessible in low-income regions. Additionally, reimbursement limitations for advanced catheter-based procedures in certain countries can restrict patient access to cutting-edge treatments.

Regulatory hurdles and stringent approval processes pose another challenge for market players. Medical device regulatory authorities such as the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and PMDA (Pharmaceuticals and Medical Devices Agency, Japan) impose strict clinical trial requirements for new catheter technologies, coatings, and materials. The time-consuming approval process can delay product launches and increase development costs.

Material biocompatibility and catheter durability are also key concerns. Catheters made from silicone, polyurethane, and PTFE (polytetrafluoroethylene) must exhibit optimal flexibility, kink resistance, and hemodynamic stability to prevent clot formation and vessel trauma. Balancing softness with durability while ensuring low thrombogenicity remains a technical challenge for manufacturers.

Additionally, the shortage of skilled healthcare professionals trained in advanced catheterization procedures is a limiting factor in some regions. Interventional cardiologists, radiologists, and vascular surgeons require specialized training to handle complex catheter-based interventions, and the lack of expertise can impact procedural success rates.

What Factors Are Driving the Growth of the Intravascular Catheters Market?

The growth in the intravascular catheters market is driven by several factors, including the rising incidence of cardiovascular diseases, the increasing use of minimally invasive interventions, and continuous innovations in catheter technology. One of the major drivers is the growing prevalence of cardiovascular disorders, such as coronary artery disease (CAD), stroke, and peripheral artery disease (PAD), which require catheter-based interventions such as angioplasty, stenting, and thrombectomy.

Another key driver is the expanding applications of catheters in oncology, nephrology, and neurology. Catheter-based chemotherapy infusion, dialysis catheters for end-stage renal disease (ESRD), and neurovascular catheters for stroke treatment are contributing to market growth. The rising global burden of cancer and kidney diseases is driving demand for long-term vascular access devices.

The increasing adoption of outpatient and home-based infusion therapies is further fueling market expansion. Peripherally inserted central catheters (PICCs) and midline catheters are being widely used for long-term antibiotic therapy, chemotherapy, and parenteral nutrition, allowing patients to receive treatment outside of hospital settings. This trend is particularly significant in chronic disease management and elderly patient care, where home-based IV therapy reduces hospital admissions and healthcare costs.

Technological advancements, such as robotic-assisted catheter navigation, real-time pressure-sensing catheters, and 3D imaging-assisted catheter placement, are enhancing the precision and safety of minimally invasive vascular procedures. The introduction of AI-driven catheter placement guidance systems is helping reduce complications, improve procedural outcomes, and shorten procedure times.

Additionally, government initiatives and healthcare investments in improving vascular access care and catheter-based treatment infrastructure are supporting market growth. Many developing countries are expanding interventional cardiology and dialysis centers, increasing the adoption of high-quality intravascular catheters and vascular access solutions.

With ongoing advancements in catheter coatings, biodegradable materials, smart sensors, and AI-driven imaging, the intravascular catheters market is poised for continuous growth and innovation. Companies that focus on infection control, cost-effective solutions, and regulatory compliance will gain a competitive advantage in meeting the evolving needs of healthcare providers and patients worldwide.

SCOPE OF STUDY:

The report analyzes the Intravascular Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Short PIVC, Integrated / Closed PIVC); Application (Oncology, Gastroenterology, Renal Disease, Infectious Diseases, Others); End-Use (Hospitals, Clinics, Ambulatory Surgery Centers, Homecare, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AMECATH
  • AngioDynamics, Inc.
  • Angiplast Pvt. Ltd.
  • Argon Medical Devices, Inc.
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company (BD)
  • Boston Scientific Corporation
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Hindustan Syringes & Medical Devices Ltd.
  • ICU Medical, Inc.
  • Johnson & Johnson
  • McKesson Corporation
  • Medline Industries, Inc.
  • Medtronic PLC
  • Nipro Medical Corporation
  • PRODiMED
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Smiths Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Intravascular Catheters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Number of Hospital Admissions and ICU Stays Drives Demand for Intravascular Catheters
    • Growth in Chronic Disease Management and Long-Term Infusions Expands Market Scope
    • Increase in Chemotherapy and Parenteral Nutrition Applications Spurs Central Venous Catheter Use
    • Advancements in Catheter Materials and Antimicrobial Coatings Reduce Infection Risks and Improve Outcomes
    • Adoption of Ultrasound-Guided Insertion Techniques Strengthens Procedural Safety and Precision
    • Rising Use of Midline and PICC Catheters in Outpatient and Home Infusion Settings Enhances Access
    • Expansion of Interventional Radiology and Cardiology Procedures Fuels Specialized Catheter Demand
    • Integration With Electronic Monitoring Systems Enables Real-Time Flow and Pressure Measurement
    • Surge in Sepsis and Critical Care Cases Highlights Importance of Reliable Vascular Access
    • AI-Based Vascular Access Planning and Patient Stratification Tools Improve Catheter Placement Strategies
    • Growing Preference for Single-Use, Sterile Devices Boosts Disposable Catheter Sales
    • Increased Demand for Short Peripheral Catheters in Emergency and Ambulatory Care Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intravascular Catheters Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intravascular Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Short PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Short PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Short PIVC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Integrated / Closed PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Integrated / Closed PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Integrated / Closed PIVC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Homecare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Renal Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Renal Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Renal Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intravascular Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Intravascular Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Intravascular Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Intravascular Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제